Achievements and Limitations of Evidence-Based Medicine

Journal of the American College of Cardiology

Volumn 68, Issue 2, 2016, Pages 204-213

  Sheridan, Desmond J ^a   Julian, Desmond G ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b Netherhall Gardens   (United Kingdom)

Author keywords

advocacy; campaign; clinical decision making; public health; United Kingdom; United States

Indexed keywords

ADVERSE OUTCOME; ANTIBIOTIC RESISTANCE; CLINICAL PRACTICE; CLINICAL STUDY; COMORBIDITY; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; HUMAN; LONG TERM CARE; MEDICAL RESEARCH; PRIORITY JOURNAL; REVIEW; STATISTICAL BIAS; STATISTICAL SIGNIFICANCE; ACHIEVEMENT; CARDIOVASCULAR DISEASES; CLINICAL DECISION MAKING; PROCEDURES; PUBLIC HEALTH; STANDARDS;

ACHIEVEMENT; CARDIOVASCULAR DISEASES; CLINICAL DECISION-MAKING; EVIDENCE-BASED MEDICINE; HUMANS; PUBLIC HEALTH;

EID: 84990212796     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.03.600     Document Type: Review

References (67)

1. 1 Guyatt, G.H., Evidence-based medicine. ACP J Club, 114, 1991, A16.
2. 2 Evidence-Based Medicine Working Group. Evidence-based medicine: a new approach to teaching the practice of medicine. JAMA 268 (1992), 2420–2425.
3. 3 Hitt, J., The year in ideas: A to Z; evidence-based medicine. The New York Times Magazine, December 9, 2001.
4. 4 Dickersin, K., Straus, S.E., Bero, L.A., Evidence based medicine: increasing, not dictating, choice. BMJ, 334(Suppl 1), 2007, s10.
5. 5 Tröhler, U., To Improve the Evidence of Medicine: The 18th Century British Origins of a Critical Approach. 2000, Royal College of Physicians of Edinburgh, Edinburgh, UK.
6. 6 Andersen, H., Mechanisms: what are they evidence for in evidence-based medicine?. J Eval Clin Pract 18 (2012), 992–999.
7. 7 Loughlin, M., Bluhm, R., Buetow, S., et al. Reason and value: making reasoning fit for practice. J Eval Clin Pract 18 (2012), 929–937.
8. 8 Sackett, D.L., Rosenberg, W.M., Gray, J.A., et al. Evidence based medicine: what it is and what it isn't. BMJ 312 (1996), 71–72.
9. 9 Osler, W., Books and men. Aequanimitas, With Other Addresses to Medical Students, Nurses and Practitioners of Medicine, 1904, P Blakiston, Philadelphia, PA.
10. 10 Brush, J.E. Jr., Halperin, J.L., Counterpoint: a baby in the bathwater: preserving evidence-based medicine. J Am Coll Cardiol, 68, 2016 XXX–XX.
11. 11 Cochrane Library Oversight Committee. Measuring the performance of The Cochrane Library. Cochrane Database Syst Rev, 12, 2012, ED000048.
12. 12 Cochrane Collaboration. Annual Report & Financial Statements 2010/11. Available at: http://community-archive.cochrane.org/news/tags/authors/collaboration%E2%80%99s-201011-annual-report-financial-statements. Accessed May 4, 2016.
13. 13 Irving, D., Managing Quality in General Practice. 1991, King's Fund, London, UK.
14. 14 Guidelines for management of asthma in adults: I. Chronic persistent asthma. Statement by the British Thoracic Society, Research Unit of the Royal College of Physicians of London, King's Fund Centre, National Asthma Campaign [published correction appears in BMJ 1990;301:924]. BMJ 301 (1990), 651–653.
15. 15 Moorthy, V.S., Karam, G., Vannice, K.S., et al. Rationale for WHO's new position calling for prompt reporting and public disclosure of interventional clinical trial results. PLoS Med, 12, 2015, e1001819.
16. 16 La Santos Quintana A. PM+: EU's clinical trials regulation ‘a step in right direction.’ Parliament Magazine. 2014. Available at: https://www.theparliamentmagazine.eu/articles/sponsored_article/pm-eu%E2%80%99s-clinical-trials-regulation-%E2%80%98-step-right-direction%E2%80%99. Accessed May 4, 2016.
17. 17 Welch, H.G., Black, W.C., Overdiagnosis in cancer. J Natl Cancer Inst 102 (2010), 605–613.
18. 18 Sakr, W.A., Grignon, D.J., Haas, G.P., et al. Age and racial distribution of prostatic intraepithelial neoplasia. Eur Urol 30 (1996), 138–144.
19. 19 The BMJ. Too much medicine. Available at: http://www.bmj.com/too-much-medicine. Accessed May 4, 2016.
20. 20 Preventing Overdiagnosis Board. Preventing overdiagnosis. Available at: http://www.preventingoverdiagnosis.net. Accessed May 4, 2016.
21. 21 ABIM Foundation, ACP–ASIM Foundation, and European Federation of Internal Medicine. Medical professionalism in the new millennium: a physician charter. Ann Intern Med 136 (2002), 243–246.
22. 22 Royal College of Physicians. Doctors in society: medical professionalism in a changing world. Report of a Working Party of the Royal College of Physicians of London. 2005. Available at: https://cdn.shopify.com/s/files/1/0924/4392/files/doctors_in_society_reportweb.pdf?15745311214883953343. Accessed May 4, 2016.
23. 23 Office of the Secretary, Department of Health, Education and Welfare, National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: ethical principles and guidelines for the protection of human subjects of research. 1979. Available at: http://archive.hhs.gov/ohrp/humansubjects/guidance/belmont.htm. Accessed May 4, 2016.
24. 24 The Bristol Royal Infirmary Inquiry. The report of the public inquiry into children's heart surgery at the Bristol Royal Infirmary 1984–1995: learning from Bristol. July 2001. Available at: http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4005620. Accessed May 16, 2016.
25. 25 Durack, D.T., The weight of medical knowledge. N Engl J Med 298 (1978), 773–775.
26. 26 Cosford P. The use of antivirals for the treatment and prophylaxis of influenza. Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/370676/Letter_to_clinicians.pdf. Accessed May 4, 2016.
27. 27 Cohen, D., GPs are told to treat with scepticism advice on anti-flu drugs from Public Health England. BMJ, 350, 2015, h258.
28. 28 Payne G, Grice D. Re: Tamiflu for the prophylaxis of influenza in nursing and care homes. Available at: http://margaretmccartney.com/wp-content/uploads/2015/01/Tamiflu-letter.pdf. Accessed May 4, 2016.
29. 29 Fryar, C., Doctors can depart from guidelines in patients’ best interests. BMJ, 350, 2015, h841.
30. 30 Aronow, W.S., Approach to symptomatic coronary disease in the elderly: TIME to change?. Lancet 358 (2001), 945–946.
31. 31 Lee, P.Y., Alexander, K.P., Hammill, B.G., et al. Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA 286 (2001), 708–713.
32. 32 Rossello, X., Pocock, S.J., Julian, D.G., Long-term use of cardiovascular drugs: challenges for research and for patient care. J Am Col Cardiol 66 (2015), 1273–1285.
33. 33 Jadad, A.R., To, M.J., Emara, M., et al. Consideration of multiple chronic diseases in randomized controlled trials. JAMA 306 (2011), 2670–2672.
34. 34 Van Spall, H.G., Toren, A., Kiss, A., et al. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA 297 (2007), 1233–1240.
35. 35 Tinetti, M.E., McAvay, G., Trentalange, M., et al. Association between guideline recommended drugs and death in older adults with multiple chronic conditions: population based cohort study. BMJ, 351, 2015, h4984.
36. 36 MIAMI Trial Research Group. Long-term prognosis after early intervention with metoprolol in suspected acute myocardial infarction: experiences from the MIAMI Trial. J Intern Med 230 (1991), 233–237.
37. 37 Roncaglioni, M.C., Collaborative Group of the Primary Prevention Project (PPP). Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet 357 (2001), 89–95.
38. 38 Reveiz, L., Chapman, E., Asial, S., et al. Risk of bias of randomized trials over time. J Clin Epidemiol 68 (2015), 1036–1045.
39. 39 Maggioni, A.P., Latini, R., Tognoni, G., et al. Pain relief, general management and other adjunctive treatments. Yusuf, S., Cairns, J.A., Camm, A.J., et al. (eds.) Evidence Based Cardiology, 2nd edition, 2003, BMJ, London, UK, 482.
40. 40 Freemantle, N., Cleland, J., Young, P., et al. β blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 318 (1999), 1730–1737.
41. 41 Department of Health. National Service Framework for Coronary Heart Disease. 2000, Department of Health, London, UK.
42. 42 Giannuzzi, P., Saner, H., Björnstad, H., et al. Secondary prevention through cardiac rehabilitation. Eur Heart J 24 (2003), 1273–1278.
43. 43 Oldridge, N.B., Guyatt, G.H., Fischer, M.E., et al. Cardiac rehabilitation after myocardial infarction. Combined experience of randomized clinical trials. JAMA 260 (1988), 945–950.
44. 44 World Health Organization (WHO). Rehabilitation and Secondary Prevention After Acute Myocardial Infarction (Euro Reports and Studies 84). 1983, WHO, Copenhagen, Denmark.
45. 45 Jolliffe, J.A., Rees, K., Taylor, R.S., et al. Exercise-based rehabilitation for coronary heart disease. Cochrane Database Syst Rev, 4, 2000, CD001800.
46. 46 Taylor, R.S., Brown, A., Ebrahim, S., et al. Exercise based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med 116 (2004), 682–692.
47. 47 West, R.R., Trials are Not Large Enough. 2005, European Society of Cardiology, Leuven, Belgium.
48. 48 West, R.R., Jones, D.A., Henderson, A.H., Rehabilitation after myocardial infarction trial (RAMIT): multi-centre randomised controlled trial of comprehensive cardiac rehabilitation in patients following acute myocardial infarction. Heart 98 (2012), 637–644.
49. 49 Dalal, H.M., Doherty, P., Taylor, R.S., Cardiac rehabilitation. BMJ, 351, 2015, h5000.
50. 50 Greenhalgh, T., Howick, J., Maskrey, N., Evidence Based Medicine Renaissance Group. Evidence based medicine: a movement in crisis?. BMJ, 348, 2014, g3725.
51. 51 Cochrane, A., Effectiveness and efficiency: random reflections on health services. 1972, Nuffield Provincial Hospitals Trust, London, UK.
52. 52 Mather, H.G., Morgan, D.C., Pearson, N.G., et al. Myocardial infarction: a comparison between home and hospital care for patients. BMJ 1 (1976), 925–929.
53. 53 Ministry of Reconstruction. Report of the Machinery of Government Committee. 1918, HMSO, London, UK.
54. 54 Cmnd 4814. The Organisation and Management of Government R&D. A Framework for Government Research and Development (The Rothschild Report), 1971, HMSO, London, UK.
55. 55 House of Lords Select Committee on Science and Technology. Priorities in Medical Research, 3rd Report Session 1987-88, HL Paper 54. 1988, HMSO, London, UK.
56. 56 Peckham, M., Research and development for the National Health Service. Lancet 338 (1991), 367–371.
57. 57 Black, N., A national strategy for research and development: lessons from England. Annu Rev Public Health 18 (1997), 485–505.
58. 58 Royal College of Physicians. Doctors in society: medical professionalism in a changing world. Report of a Working Party of the Royal College of Physicians of London. 2005, RCP, London, UK.
59. 59 Tunis, S.R., Lack of evidence for clinical and health policy decisions. BMJ, 347, 2013, f7155.
60. 60 Iacobucci, G., The battle for NHS111: who should run it now. BMJ, 348, 2014, f7659.
61. 61 Kmietowicz, Z., Repeal “intensely damaging” health act, says BMA. BMJ, 348, 2014, g2532.
62. 62 Fleming A. Penicillin. Nobel Lecture, December 11, 1945. Available at: http://www.nobelprize.org/nobel_prizes/medicine/laureates/1945/fleming-lecture.pdf. Accessed May 5, 2016.
63. 63 Florey HW. Penicillin. Nobel Lecture, December 11, 1945. Available at: http://www.nobelprize.org/nobel_prizes/medicine/laureates/1945/florey-lecture.pdf. Accessed May 5, 2016.
64. 64 O'Neill J. Review on antimicrobial resistance: tackling a crisis for the health and wealth of nations. 2014. Available at: http://amr-review.org/sites/default/files/AMR%20Review%20Paper%20-%20Tackling%20a%20crisis%20for%20the%20health%20and%20wealth%20of%20nations_1.pdf. Accessed May 5, 2016.
65. 65 The White House, Office of the Press Secretary. Fact sheet: President's 2016 budget proposes historic investment to combat antibiotic-resistant bacteria to protect public health. January 27, 2015. Available at: https://www.whitehouse.gov/the-press-office/2015/01/27/fact-sheet-president-s-2016-budget-proposes-historic-investment-combat-a. Accessed May 5, 2016.
66. 66 Gabbey, J., Walley, T., Introducing new health interventions. BMJ 332 (2006), 64–65.
67. 67 Heath, I., Role of fear in overdiagnosis and overtreatment—an essay by Iona Heath. BMJ, 349, 2014, g6123.